FDA Approves First Medication for Obstructive Sleep Apnea
Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity, to be used in...
FDA approves weight loss drug Zepbound for sleep apnea - NBC News
Dec 20, 2024 · The Food and Drug Administration expanded the approval of weight loss drug Zepbound to treat obstructive sleep apnea in adults with obesity, the drugmaker Eli Lilly said Friday. The decision...
GLP-1 Zepbound Is Approved As First Drug For Sleep Apnea - U.S. News …
MONDAY, Dec. 23, 2024 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the...
FDA Approves Zepbound for Obstructive Sleep Apnea - WebMD
Dec 23, 2024 · Results showed that Zepbound significantly reduced breathing interruptions (apnea and hypopnea) during sleep compared to the placebo. More patients treated with Zepbound saw their symptoms...
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
Dec 20, 2024 · For people with obstructive sleep apnea, Zepbound should be used with a reduced-calorie diet and increased physical activity, drugmaker Eli Lilly said. The US Food and Drug Administration on...
FDA approves Zepbound® (tirzepatide) as the first and only …
Zepbound ® (tirzepatide) injection is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity. It is also approved in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in ...
Zepbound approved for sleep apnea - USA TODAY
Dec 20, 2024 · The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea ...
Dec 20, 2024 · Zepbound could be a valuable new treatment option for patients with OSA, which can lead to loud snoring and excessive daytime sleepiness, and can contribute to serious complications including...
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term
Jun 21, 2024 · The company released additional data from two late-stage trials showing that Zepbound helped resolve obstructive sleep apnea in almost half of patients. The results add to growing evidence of...
FDA approves weight loss drug Zepbound to treat sleep apnea : …
Dec 21, 2024 · The Food and Drug Administration on Friday authorized the use of Zepbound, made by Eli Lilly & Co., for adults with obesity and moderate to severe obstructive sleep apnea (OSA), a common...